ANAPTYSBIO, INC - COM (ANAB)

Historical Portfolio Holders from Q1 2017 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
29.8M
Holdings value Q2 2024
$747M
Value change Q2 2024
+$18.5M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
132
Number of buys Q2 2024
23
Number of sells Q2 2024
-7
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.3M $43.6M +$13.6M $33.50 42
2024 Q2 29.8M $747M +$18.5M $25.06 132
2024 Q1 29.2M $657M -$21M $22.52 130
2023 Q4 30.1M $646M +$662K $21.42 116
2023 Q3 30.3M $544M -$1.74M $17.96 115
2023 Q2 30.2M $614M -$16.3M $20.34 115
2023 Q1 31M $675M -$44.6M $21.76 112
2022 Q4 32.8M $1.02B -$10.5M $30.99 112
2022 Q3 32.6M $831M +$39.1M $25.51 108
2022 Q2 31.2M $633M +$28.5M $20.30 118
2022 Q1 29.7M $735M +$14M $24.74 124
2021 Q4 27.8M $964M +$8.86M $34.75 133
2021 Q3 27.6M $749M -$4.36M $27.12 123
2021 Q2 27.8M $721M -$34.1M $25.93 117
2021 Q1 29.2M $629M +$26.2M $21.55 116
2020 Q4 27.9M $601M -$16.7M $21.50 128
2020 Q3 29.1M $430M -$16.5M $14.75 126
2020 Q2 30M $670M -$17.2M $22.34 118
2020 Q1 31.2M $441M +$44.1M $14.13 111
2019 Q4 28.3M $460M -$211M $16.25 118
2019 Q3 29M $1.02B -$48.5M $34.99 118
2019 Q2 30.2M $1.7B +$118M $56.42 125
2019 Q1 29.1M $2.13B +$19.4M $73.05 128
2018 Q4 29M $1.85B -$11.2M $63.79 119
2018 Q3 28.6M $2.85B +$379M $99.77 131
2018 Q2 24.9M $1.77B +$926K $71.04 121
2018 Q1 24.3M $2.53B +$62.8M $104.08 134
2017 Q4 23.8M $2.39B +$693M $100.72 116
2017 Q3 17.6M $616M +$142M $34.95 70
2017 Q2 13.7M $328M -$1.8M $23.93 51
2017 Q1 13.8M $381M +$374M $27.75 49